Analysis of the risk factors for severity in post endoscopic retrograde cholangiopancreatography pancreatitis: The indication of prophylactic treatments

doi:10.4253/wjge.v9.i4.189

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9548)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

377

WORD

341

HTML

2837

Figures (1-1)

243

Tables (1-5)

205

Sum=4003

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

785

Download

1527

Sum=2312

Publishing Process of This Article

Item

Count

Browse

1166

Download

2067

Sum=3233

Apr 16, 2017 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Endosc. Apr 16, 2017; 9(4): 189-195
Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.189

Full Size Figure Download Figure

Figure 1 Patients’ flow chart. ERCP: Endoscopic retrograde cholangiopancreatography; PEP: Post endoscopic retrograde cholangiopancreatography pancreatitis.

Citation: Matsubara H, Urano F, Kinoshita Y, Okamura S, Kawashima H, Goto H, Hirooka Y. Analysis of the risk factors for severity in post endoscopic retrograde cholangiopancreatography pancreatitis: The indication of prophylactic treatments. World J Gastrointest Endosc 2017; 9(4): 189-195
URL: https://www.wjgnet.com/1948-5190/full/v9/i4/189.htm
DOI: https://dx.doi.org/10.4253/wjge.v9.i4.189